in heavily calcified lesions or locations subject to external compression.
It features a stainless steel scaffold covered with a thin layer of ePTFE (polytetrafluoroethylene), allowing it to act as a scaffold while providing a barrier against tissue ingrowth. Key Clinical and Regulatory Milestones g60511.mp4
The iCARUS clinical trial demonstrated a 96.4% primary patency rate at 9 months, showing the device is highly effective for vascular treatment. in heavily calcified lesions or locations subject to
According to the official Instructions for Use (IFU) , medical professionals should note: According to the official Instructions for Use (IFU)
As of March 2024, Cook Medical entered an exclusive agreement with Getinge to distribute the iCast system in the United States. Safety and Recalls
FDA MedWatch - iCast Covered Stent by Atrium Medical: - GovDelivery
Used for treating iliac arterial occlusive disease (narrowed arteries in the groin/leg area).